Support: This study was supported by CAPES, CNPq and Fapemig. AMM received a CAPES scholarship during her Master course.
approximately 2:1 9 . It is also reported to be common in elderly men 1, 2, 5 . Over the past decades, advances in treatment have changed the prognosis of MG, but spontaneous remission is not frequent and the impact on the quality of life of patients still significant 10 . The report of the quality of life by the patient may in fluence therapeutic decisions and enable a better understan ding of his/her demands, paving the way for an optimal clinical support 11, 12 . The more specific the questionnaire, the more likely it includes only items relevant to the disease, avoiding unnecessary statements 13 .
The aim of the current study is to perform the transla tion and cross-cultural adaptation of an instrument designed to specifically assess the quality of life of MG patients named "Questionnaire of Life Quality Specific for Myas thenia Gravis -15 items" (MG-QOL15) 12 . We expect this instrument may contribute to the evaluation of patients in both clinical and research settings, providing a reliable view on the physical, psychological and social wellbeing of Brazilian patients with MG.
METhod

Instrument
The MGQOL15 12 originated from a list of 60 items co vering specific features of health relatedquality of life in MG. The main objective of MGQOL15 is to provide an effec tive, fast and easy way to evaluate, and to interpret the quality of life of MG patients. Each item is scored from zero to four according to its frequency, scoring a maximum of 60. The higher the score, the worse it is perceived the quality of life by the patient.
Translation, reverse translation and final version
To translate the MGQOL15 into Portuguese, two authors performed independently the initial translation of the instrument. Both versions were then reviewed by a third author to build a single revised version in Portuguese. This revised version was backtranslated into English by a fourth author. The reverse-translated version was compared to the original English version, and any discrepancy was corrected in the Portuguese text to keep the original meaning. This final Portuguese version was used in the testing phase described bellow.
Testing phase
We randomly recruited ten patients over 18 yearsold who are followed at the Neuromuscular Diseases Clinic of the University Hospital, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
The following demographic and clinical data were collected: age, gender, marital status, educational level, early and current symptoms of MG, and therapeutic strategies. MG was categorized according to the Myasthenia Gravis Foundation of America Clinical Classification (MGFA) 1 . The MG Composite 13 was used to assess the current severity of MG clinical signs and symptoms. In addition, the Medical Outcomes Study 36Item ShortForm Health Survey (SF36) 14 and the Hospital Anxiety and Depression Scale (HADS) 15 were applied. SF36 is one of the most widely used instruments to assess quality of life in clinical and research settings, being composed of eight health related domains (physical functioning, rolephysical, bodily pain, general health, vitality, social functioning, roleemotional and mental health). The HADS comprises 14 items, seven to assess anxiety (HADA) and seven depression (HADD).
MG-QOL15 was applied to 10 patients with MG. Patients commented on their difficulties in understanding each statement and the misunderstood items were pointed out and subsequently revised by the authors. The objective of this step was to verify whether each item was clearly understood and consistent with its original meaning.
The study was approved by the Research Ethics Com mittee of the Universidade Federal de Minas Gerais (ETIC no. 0476.0.203.00011). All subjects gave their written informed consent to participate in the study.
RESuLTS
The clinical and sociodemographic features of the patients are depicted in Table 1 . Nine patients (90%) were female, aged 25 to 57 yearsold, and 80% attended at least 8 years of school. Five patients (50%) had ocular symptoms as the initial complaint, and seven (70%) reported bulbar manifestations as being the main problem. During testing phase, patients had difficulty in interpre ting and understanding the items 8, 13 and 15. As an example, regarding the adaptations in statement 8, the expression 'professional status' (original version) was replaced by 'my position at work' (backtranslation version) due to the difficulty of all patients to understand the word 'status'. To ease comprehension, the word "cargo"(meaning job function) was introduced in parenthesis after the expression 'my position at work'. After entering the word "cargo", the comprehension became effective. For the analysis and discussion of all statements, meetings were held among the authors, reaching the final Portuguese version.
Seven patients had a score above 25 in MGQOL15, and items 3, 5, 7, 8 and 9 showed the highest scores ( Table 2) . A negative correlation was observed between MG-QOL15 and total SF36 score (p<0.05; rho=60) due to a very significant correlation between MG-QOL15 and the general health domain of SF36 (p<0.001; rho=91). A significant positive correlation was also observed between MGQOL15 and the HADS (p<0.05; rho=63).
dISCuSSIon
The MGQOL15 was originally proposed and published in English, being derived from a list of 60 items covering features of health related-quality of life in MG 16 . The ori ginal study showed that MG-QOL15 correlated with clinical measures of MG, indicating its construct validity. In the current study, we performed the translation and crosscultural adaptation to Portuguese, and the initial validation of the MG-QOL15 12 . The Brazilian version of MGQOL15 was well understood and accepted by the patients. To perform a concurrent validation, MGQOL15 was correlated with the SF36. SF36 has been already validated in Portuguese and is one of the most popular instruments to assess the quality of life rela ted to health 14 . There was a negative correlation between MG QOL15 and the general health domain of SF36. As expected, the higher the MG-QOL15 score (i.e. more symptoms and incapacity attributed to the disease), the worse the perception of the general health status by the patient. This is in line with the results of the other two studies with the MG-QOL15 12, 17 . Indeed the frequency and severity of MG symptoms are wellknown factors that influence the patient's perception of his/her quality of life 15, 12 . Therefore, besides translating and adapting MGQOL15, this study provides preliminary evidence for the validity of the instrument.
Anxiety disorder and depression are frequent comorbid conditions in MG, and they can also influence quality of life 9, 10 . The QOLMG15 correlated positively with the HADS, suggesting that the worse the perception of the quality of life, the higher the likelihood of being depressed or anxious, which is in agreement with the literature [9] [10] [11] . This indicates that it is important to look beyond the physical or somatic symptoms of the disease in order to provide an optimal clinical assistance to MG patients.
Other disease relatedfactors may influence quality of life in MG such as the type of the predominant symptom, the number of myasthenic crisis and drug treatment 35, 12 . The small number of patients enrolled in this report prevented the assessment of these associations, and further investigation is warranted. It is worth mentioning that the authors of the original questionnaire did not recommend any cut off value for the categorization of the quality of life of patients with MG 12 . They only assumed that the higher the score the worse the quality of life, with a maximum score of 60. Despite limited sample size, the mean value of MGQOL15 of our patients was similar to the value reported in the original study of the instrument 12 .
In conclusion, this study presents a promising instrument, which was easily applied and interpreted by the physician, to assess the quality of life in MG. It also indicates that the severity of motor symptoms and the presence of psychiatric symptoms influence the quality of life of Brazilian patients with MG. Further studies involving lar ger samples are necessary to validate the MGQOL15, and to provide more robust data on the factors influencing the quality of life in MG.
